Consensus Biohaven Ltd.

Equities

BHVN

VGG1110E1079

Real-time Estimate Cboe BZX Other stock markets 02:12:10 2024-05-10 pm EDT			5-day change	1st Jan Change
35.92 ^USD	-11.74%		+1.98%	-4.93%

05:37pm	Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates	MT
Apr. 25	Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Biohaven Ltd.

Price target over the last 5 years

History of analyst recommendation changes

54c749c917536df5cf038b64.N0gbqLPW_2fpaW56nkhbfX9I7Ig_j4opAphtxlzFILs.TQ9Yn8GRtiHQORdPrQ4zFSAjpd120NVQTPQfkgqscfFNcXLEgZvJX6gEKw~acf1abe79d7057ea481df47e23b9f522

Analyst Recommendations on Biohaven Ltd.

Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	Apr. 25	MT
Biohaven Launches $200 Million Common Stock Offering	Apr. 17	MT
BTIG Starts Biohaven Pharmaceutical Holding at Buy With $24 Price Target	22-12-02	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

41.36 USD

Average target price

57.67 USD

Spread / Average Target

+39.43%

High Price Target

66 USD

Spread / Highest target

+59.57%

Low Price Target

50 USD

Spread / Lowest Target

+20.89%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar